PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
87.81%
Revenue growth above 1.5x TSM's 13.64%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
103.57%
Gross profit growth above 1.5x TSM's 13.87%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
217.76%
EBIT growth above 1.5x TSM's 15.53%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
217.76%
Operating income growth above 1.5x TSM's 15.53%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
202.89%
Net income growth above 1.5x TSM's 9.92%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
201.20%
EPS growth above 1.5x TSM's 9.86%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
204.88%
Diluted EPS growth above 1.5x TSM's 9.86%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.12%
Share count expansion well above TSM's 0.00%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.36%
Diluted share count expanding well above TSM's 0.00%. Michael Burry would fear significant dilution to existing owners' stakes.
0.89%
Dividend growth under 50% of TSM's 16.66%. Michael Burry might suspect more pressing needs for cash or weaker earnings power.
118.07%
Positive OCF growth while TSM is negative. John Neff would see this as a clear operational advantage vs. the competitor.
127.53%
Positive FCF growth while TSM is negative. John Neff would see a strong competitive edge in net cash generation.
1208.60%
10Y revenue/share CAGR above 1.5x TSM's 267.98%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
324.63%
5Y revenue/share CAGR above 1.5x TSM's 179.39%. David Dodd would look for consistent product or market expansions fueling outperformance.
248.11%
3Y revenue/share CAGR above 1.5x TSM's 80.98%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
6130.13%
10Y OCF/share CAGR above 1.5x TSM's 361.96%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
582.64%
5Y OCF/share CAGR above 1.5x TSM's 220.70%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
303.63%
3Y OCF/share CAGR above 1.5x TSM's 101.48%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
5974.42%
Net income/share CAGR above 1.5x TSM's 315.14% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
451.81%
5Y net income/share CAGR above 1.5x TSM's 271.21%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
891.23%
3Y net income/share CAGR above 1.5x TSM's 84.46%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
524.07%
10Y equity/share CAGR above 1.5x TSM's 332.39%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
207.00%
5Y equity/share CAGR 1.25-1.5x TSM's 144.00%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
96.93%
3Y equity/share CAGR similar to TSM's 91.49%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
118.44%
Dividend/share CAGR of 118.44% while TSM is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
7.89%
Dividend/share CAGR of 7.89% while TSM is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
0.64%
Below 50% of TSM's 40.01%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
73.19%
AR growth well above TSM's 4.08%. Michael Burry fears inflated revenue or higher default risk in the near future.
-6.33%
Inventory is declining while TSM stands at 2.01%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
11.46%
Asset growth above 1.5x TSM's 3.36%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
12.02%
BV/share growth above 1.5x TSM's 4.21%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-9.32%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
8.80%
R&D growth drastically higher vs. TSM's 4.23%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
-1.74%
We cut SG&A while TSM invests at 15.53%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.